Avicel RC-591 NF Bulk Powder Recalled for Microbial Contamination
DuPont Nutrition USA is recalling Avicel RC-591 NF bulk powder (lot #2173766940) due to out-of-specification microbial contamination. The product was distributed as a component in finished drug formulations nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified as FDA Class I by the issuing agency. Per the severity rubric, FDA Class I recalls with microbial contamination of a drug ingredient warrant a minimum score of 4 (Severe), even absent reported illnesses, because of the risk of harm to patients who may receive contaminated drug products.
Plain-English summary
DuPont Nutrition USA, Inc. is recalling Avicel RC-591 NF (a microcrystalline cellulose and carboxymethylcellulose sodium blend) supplied in 80 kg drums. The recall was initiated because the product failed microbial testing, with total aerobic microbial count (TAMC) results exceeding specifications.
The affected lot (#2173766940) was distributed to one account that may have incorporated it as a component into finished drug formulations, which were then distributed nationwide in the United States.
Consumers and healthcare providers who have received drug products containing this ingredient should contact the recalling firm or their healthcare provider for further guidance. The source text does not specify actions such as product returns or destruction procedures.
The recalled product
- Product
- Avicel RC-591 NF (MCC/Carboxymethylcellulose Sodium) NF, bulk powder, 80.0 KG drum, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711
- Manufacturer
- DuPont Nutrition USA, Inc
- Hazard
- microbial-contamination
- tamc-out-of-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # 2173766940
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27